Plasma levels of IL-9, IL-21 and IL-23 were similar in patients with and without post-transplant AR, BR, patients with and without rejection (AR + BR), ATN or DGF (Table 2). The gene discussed is IL21; the disease is oculocutaneous albinism type 1.